Evidence map›Paper›PMID 31759078›Full record

ArticleInternational journal of radiation oncology, biology, physics2020

High-Dose Radiation Increases Notch1 in Tumor Vasculature.

Debarshi Banerjee, Sunjay M Barton, Peter W Grabham, Ariela L Rumeld, Shunpei Okochi, Cherease Street, Angela Kadenhe-Chiweshe, Shuobo Boboila, Darrell J Yamashiro, Eileen P Connolly

Open access · greenAbstract read
In one paragraph

Article in International journal of radiation oncology, biology, physics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 20 citations in OpenAlex.

  1. Trial
  2. Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025
    Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. 2Molecular imaging and biology · 2024
    Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Inactivation ofCancer research communications · 2022
    Article
  13. Notch signaling pathway: architecture, disease, and therapeutics.Signal transduction and targeted therapy · 2022
    Review
  14. Review
  15. Review
  16. Endothelial-to-Mesenchymal Transition in Cancer.Frontiers in cell and developmental biology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Debarshi BanerjeeDepartment of Pediatrics, Columbia University Irving Medical Center, New York, New York.
Sunjay M BartonDepartment of Radiation Oncology, Columbia University Irving Medical Center, New York, New York.
Peter W GrabhamCenter for Radiological research, Columbia University Irving Medical Center, New York, New York.
Ariela L RumeldDepartment of Surgery, Columbia University Irving Medical Center, New York, New York.
Shunpei OkochiDepartment of Surgery, Columbia University Irving Medical Center, New York, New York.
Cherease StreetDepartment of Radiation Oncology, Columbia University Irving Medical Center, New York, New York.
Angela Kadenhe-ChiwesheDepartment of Surgery, Columbia University Irving Medical Center, New York, New York.
Shuobo BoboilaDepartment of Radiation Oncology, Columbia University Irving Medical Center, New York, New York.
Darrell J YamashiroDepartment of Pediatrics, Columbia University Irving Medical Center, New York, New York; Department of Pathology & Cell Biology, Columbia University Irving Medical Center, New York, New York. Electronic address: dy39@cumc.columbia.edu.
Eileen P ConnollyDepartment of Radiation Oncology, Columbia University Irving Medical Center, New York, New York.
Columbia University Irving Medical Center · US

Funding

Tumor Biology and Microenvironment ProgramP30CA013696 · NCI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Anil K Rustgi · 1985 to 2026
$115.3M
Small Animal CT Image Guided Xray Irradiation SystemS10OD010631 · OD · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI WUU, CHENG-SHIE · 2012 to 2012
$590k
NCI NIH HHS P30 CA013696NIH HHS S10 OD010631
6 · The paper itself

Abstract

purposeThe aim of this study is to characterize the effects of high-dose radiation therapy (HDRT) on Notch signaling components of the tumor vasculature. METHODS AND MATERIALS: Human umbilical vein endothelial cells monolayers were exposed to different single fraction doses of irradiation; ribonucleic acid RNA was isolated and polymerase chain reaction was performed for Notch signaling components. The vascular response to radiation therapy was examined in a xenograft model of neuroblastoma. Tumors were treated with 0 Gy, 2 Gy, and 12 Gy single fraction doses and analyzed by double immunofluorescence staining for Notch1, Notch ligands Jagged1 and Dll4, and the endothelial cell (EC) marker endomucin. To assess the role of Notch in vivo, NGP xenograft tumors expressing Fc or Notch1-

resultsIn human umbilical vein endothelial cells monolayers doses ≥8 Gy increased expression of NOTCH1, JAG1, and Notch target genes HEY1 and HEY2 as early as 6 hours after irradiation. In vivo, 12 Gy significantly increased Notch1 and Jagged1 in tumor ECs compared with 0 Gy or 2 Gy after 72 hours. Combining HDRT with Notch inhibition using the Notch1-

conclusionsHDRT induced Notch1 expression and increased Notch1 signaling in the endothelial component of tumor vasculature, which was not observed with lower doses. This increase in Notch1 activation might protect tumor vessels from HDRT induced damage and regulate EndMT process.

Indexed as

Radiation DosageAnimalsBasic Helix-Loop-Helix ProteinsCell Line, TumorCell Transformation, NeoplasticEpithelial-Mesenchymal TransitionFemaleGene Expression Regulation, NeoplasticHumansHuman Umbilical Vein Endothelial CellsJagged-1 ProteinMiceMice, NudeNeovascularization, PathologicRadiotherapy DosageReceptor, Notch1Basic Helix-Loop-Helix ProteinsHEY2 protein, humanJagged-1 ProteinReceptor, Notch1Repressor Proteins

Identifiers

PMID31759078
PMCPMC8048139
OpenAlexW2990733775

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.